Abdel-Rahman A, Shetty A K, Abou-Donia M B
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Neuroscience. 2002;113(3):721-41. doi: 10.1016/s0306-4522(02)00176-8.
We hypothesize that a single exposure to an LD(50) dose of sarin induces widespread early neuropathological changes in the adult brain. In this study, we evaluated the early changes in the adult brain after a single exposure to different doses of sarin. Adult male rats were exposed to sarin by a single intramuscular injection at doses of 1, 0.5, 0.1 and 0.01 x LD(50). Twenty-four hours after the treatment, both sarin-treated and vehicle-treated (controls) animals were analyzed for: (i) plasma butyrylcholinesterase (BChE) activity; (ii) brain acetylcholinesterase (AChE) activity, (iii) m2 muscarinic acetylcholine receptor (m2 mAChR) ligand binding; (iv) blood brain barrier (BBB) permeability using [H(3)]hexamethonium iodide uptake assay and immunostaining for endothelial barrier antigen (EBA); and (v) histopathological changes in the brain using H&E staining, and microtubule-associated protein (MAP-2) and glial fibrillary acidic protein immunostaining. In animals treated with 1 x LD(50) sarin, the significant changes include a decreased plasma BChE, a decreased AChE in the cerebrum, brainstem, midbrain and the cerebellum, a decreased m2 mAChR ligand binding in the cerebrum, an increased BBB permeability in the cerebrum, brainstem, midbrain and the cerebellum associated with a decreased EBA expression, a diffuse neuronal cell death and a decreased MAP-2 expression in the cerebral cortex and the hippocampus, and degeneration of Purkinje neurons in the cerebellum. Animals treated with 0.5 x LD(50) sarin however exhibited only a few alterations, which include decreased plasma BChE, an increased BBB permeability in the midbrain and the brain stem but without a decrease in EBA expression, and degeneration of Purkinje neurons in the cerebellum. In contrast, animals treated with 0.1 and 0.01 x LD(50) did not exhibit any of the above changes. However, m2 mAChR ligand binding in the brainstem was increased after exposure to all doses of the sarin.Collectively, the above results indicate that, the early brain damage after acute exposure to sarin is clearly dose-dependent, and that exposure to 1 x LD(50) sarin induces detrimental changes in many regions of the adult rat brain as early as 24 hours after the exposure. The early neuropathological changes observed after a single dose of 1 x LD(50) sarin could lead to a profound long-term neurodegenerative changes in many regions of the brain, and resulting behavioral abnormalities.
我们假设,单次暴露于半数致死剂量(LD[50])的沙林毒气会在成年大脑中引发广泛的早期神经病理学变化。在本研究中,我们评估了成年大鼠单次暴露于不同剂量沙林毒气后大脑的早期变化。成年雄性大鼠通过单次肌肉注射接受1、0.5、0.1和0.01×LD[50]剂量的沙林毒气。治疗24小时后,对接受沙林毒气治疗的动物和接受载体治疗的(对照)动物进行以下分析:(i)血浆丁酰胆碱酯酶(BChE)活性;(ii)脑乙酰胆碱酯酶(AChE)活性;(iii)M2毒蕈碱型乙酰胆碱受体(m2 mAChR)配体结合;(iv)使用[H(3)]碘化六甲铵摄取试验和内皮屏障抗原(EBA)免疫染色评估血脑屏障(BBB)通透性;以及(v)使用苏木精-伊红(H&E)染色、微管相关蛋白(MAP-2)和胶质纤维酸性蛋白免疫染色评估大脑的组织病理学变化。在接受1×LD[50]沙林毒气治疗的动物中,显著变化包括血浆BChE降低、大脑、脑干、中脑和小脑中的AChE降低、大脑中的m2 mAChR配体结合降低、大脑、脑干、中脑和小脑中的BBB通透性增加,同时EBA表达降低、弥漫性神经元细胞死亡以及大脑皮质和海马体中MAP-2表达降低,以及小脑中浦肯野神经元变性。然而,接受0.5×LD[50]沙林毒气治疗的动物仅表现出少数改变,包括血浆BChE降低、中脑和脑干中的BBB通透性增加,但EBA表达未降低,以及小脑中浦肯野神经元变性。相比之下,接受0.1和0.01×LD[50]沙林毒气治疗的动物未表现出上述任何变化。然而,暴露于所有剂量的沙林毒气后,脑干中的m2 mAChR配体结合增加。总体而言,上述结果表明,急性暴露于沙林毒气后的早期脑损伤明显呈剂量依赖性,并且暴露于1×LD[50]沙林毒气会在暴露后24小时内就使成年大鼠大脑的许多区域出现有害变化。单次剂量1×LD[50]沙林毒气后观察到的早期神经病理学变化可能会导致大脑许多区域出现严重的长期神经退行性变化,并导致行为异常。